Sale!

CAV3 Gene Long QT syndrome type 9 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The CAV3 gene Long QT syndrome type 9 genetic test is a specialized diagnostic tool designed to identify mutations in the CAV3 gene, which are associated with Long QT Syndrome type 9 (LQT9). Long QT Syndrome is a disorder of the heart’s electrical system, characterized by prolonged QT intervals on an ECG, which can lead to sudden, uncontrollable arrhythmias and potentially fatal cardiac events. The CAV3 gene plays a critical role in the structure and function of heart muscle cells, and mutations in this gene can disrupt the heart’s electrical activity, leading to the symptoms of LQT9.

This genetic test is crucial for individuals with a family history of Long QT Syndrome or unexplained sudden cardiac deaths, as it can help in the early diagnosis and management of the condition. Early detection through genetic testing allows for the implementation of lifestyle changes, medical interventions, and possibly preventatives measures for at-risk family members, significantly reducing the risk of life-threatening cardiac events.

The test is available at DNA Labs UAE, a leading facility in genetic testing and diagnostics, ensuring high standards of accuracy and reliability. The cost of the CAV3 gene Long QT syndrome type 9 genetic test is 4400 AED, reflecting the sophisticated technology and expertise required to perform this specialized diagnostic procedure. By opting for this test at DNA Labs UAE, individuals can gain crucial insights into their genetic predisposition to LQT9, enabling informed decisions about their health and preventive care.

Description

CAV3 Gene Long QT Syndrome Type 9 Genetic Test

Test Name: CAV3 Gene Long QT Syndrome Type 9 Genetic Test

Components: CAV3 gene

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Cardiovascular Pneumology Disorders

Doctor: Cardiologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for CAV3 Gene Long QT syndrome type 9 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CAV3 Gene Long QT syndrome type 9 NGS Genetic DNA Test gene CAV3

Test Details: CAV3 gene long QT syndrome type 9 NGS genetic test is a genetic test that detects mutations in the CAV3 gene, which is associated with long QT syndrome type 9 (LQT9). Long QT syndrome is a heart rhythm disorder that can cause potentially life-threatening arrhythmias. NGS (Next-Generation Sequencing) technology is used to analyze the DNA sequence of the CAV3 gene and identify any genetic variations or mutations that may be present. This test can help in diagnosing LQT9 and determining the risk of developing life-threatening arrhythmias. By identifying specific mutations in the CAV3 gene, healthcare professionals can provide appropriate medical management, including medication or implantation of a cardiac defibrillator, to prevent sudden cardiac events in individuals with LQT9. Additionally, this genetic test can help in identifying family members who may also be at risk and require testing or monitoring. It is important to note that this test is typically ordered by a healthcare professional and is not a direct-to-consumer genetic test. Genetic counseling is often recommended before and after undergoing genetic testing to discuss the implications of the results and provide support to individuals and their families.

Test Name	CAV3 Gene Long QT syndrome type 9 Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Cardiovascular Pneumology Disorders
Doctor	Cardiologist
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for CAV3 Gene Long QT syndrome type 9 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CAV3 Gene Long QT syndrome type 9 NGS Genetic DNA Test gene CAV3
Test Details	CAV3 gene long QT syndrome type 9 NGS genetic test is a genetic test that detects mutations in the CAV3 gene, which is associated with long QT syndrome type 9 (LQT9). Long QT syndrome is a heart rhythm disorder that can cause potentially life-threatening arrhythmias. NGS (Next-Generation Sequencing) technology is used to analyze the DNA sequence of the CAV3 gene and identify any genetic variations or mutations that may be present. This test can help in diagnosing LQT9 and determining the risk of developing life-threatening arrhythmias. By identifying specific mutations in the CAV3 gene, healthcare professionals can provide appropriate medical management, including medication or implantation of a cardiac defibrillator, to prevent sudden cardiac events in individuals with LQT9. Additionally, this genetic test can help in identifying family members who may also be at risk and require testing or monitoring. It is important to note that this test is typically ordered by a healthcare professional and is not a direct-to-consumer genetic test. Genetic counseling is often recommended before and after undergoing genetic testing to discuss the implications of the results and provide support to individuals and their families.